Michael Lemp By Natalie Morrison 21-Sep-2011 - Last updated on 22-Sep-2011 at 09:47 GMT Facebook Twitter Linkedin Email to a friend Corneal specialist Lemp’s research focus is in dry eye and ocular surface disease where his work stands as the worldwide standard for the design of clinical trials for dry eye. He is currently chief medical officer of Tearlab. Thomas Christély, CEO at Silence Therapeutics Gary Foulks, member InSite Vision's new scientific advisory board Kamran Hosseini leader of InSite Vision's new scientific advisory board Michael Lemp, member of InSite Vison's new scientific advisory board Brian Levy, helping to lead InSite Vision's new scientific advisory board Richard Lindstrom, member of InSite Vision's new scientific advisory board Kelly Nichols, member of InSite Vision's new scientific advisory board Dennis Kim, chief medical officer at Zafgen Helen Tayton-Martin, executive director at Adaptimmune Jonathan Knowles, non-executive board member at Adaptimmune Prev 1 2 3 4 5 6 … 10 Next